CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement
Stocks in this Quantisnow insightHealth Care
Historical context for CLGN
Across the 10 sessions after earlier CLGN headlines, the stock closed higher 4 times and lower 6 times, with a median move of 2.8% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | CLGN | SPY |
|---|---|---|---|
| Mar 18, 2026 | CollPlant Biotechnologies Launches Redesigned Corporate Website | +1.7% | -1.4% |
| Mar 11, 2026 | COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS | -1.6% | -0.1% |
| Feb 26, 2026 | CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler | -3.9% | -0.6% |
| Feb 23, 2026 | CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex | -3.2% | -1.0% |
| Feb 17, 2026 | CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments | -11.9% | +0.2% |
| Feb 5, 2026 | COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING | -53.4% | -1.2% |
Keep researching CLGN
Quantisnow market dataNASDAQ
CLGN
CollPlant Biotechnologies Ltd
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Industrial Specialties
Get push alerts for CLGN
Full CLGN profile on Quantisnow Follow CLGN and get a push notification the moment its next story breaks.